Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $14.3M | $21.3M | $18.0M | $22.8M | $54.2M | $26.6M |
| Revenue growth | — | — | — | 49.4% | -15.7% | 26.7% | 138.1% | -51.0% |
| Gross profit | — | — | $9.35M | $11.7M | -$1.69M | $6.75M | — | — |
| Gross margin | — | — | 65.5% | 54.8% | -9.4% | 29.7% | — | — |
| Operating income | — | -$564K | -$152M | -$109M | -$25.6M | -$192M | -$38.4M | -$61.3M |
| Operating margin | — | — | -1064.0% | -511.2% | -142.4% | -844.4% | -70.7% | -230.9% |
| Net income | — | $2.51M | -$208M | -$100M | $14.2M | -$196M | -$57.9M | -$91.7M |
| Net margin | — | — | -1458.4% | -469.3% | 79.0% | -862.0% | -106.8% | -345.4% |
| EPS (diluted) | — | -$0.03 | -$11.31 | -$1.49 | $0.95 | -$11.02 | -$2.64 | -$3.59 |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | -$1.10M | -$63.2M | -$110M | -$138M | -$38.7M | -$6.40M | -$13.3M |
| Capital expenditures | — | — | $27.8M | $6.20M | $5.24M | $1.05M | $161K | — |
| Free cash flow | — | — | -$91.0M | -$116M | -$143M | -$39.7M | -$6.56M | — |
| Share buybacks | — | — | $256K | — | — | — | — | — |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $24.7K | $917K | $54.3M | $37.2M | $14.0M | $227K | $738K | $6.17M |
| Total assets | $174K | $292M | $431M | $414M | $401M | $144M | $133M | $107M |
| Total liabilities | $151K | $11.0M | $412M | $315M | $202M | $103M | $124M | $145M |
| Shareholders' equity | $23.9K | -$327M | -$531M | $99.4M | $199M | $41.0M | $8.84M | -$38.1M |
| Retained earnings | -$1.10K | $2.51M | -$564M | -$664M | -$645M | -$842M | -$900M | -$991M |
| Shares (wtd avg diluted) | — | — | 18.5M | 67.1M | 15.0M | 17.8M | 21.9M | 25.6M |
Every figure is extracted from Celularity Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.